Cargando…

HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1

We have previously discovered that HDAC6 regulates the DNA damage response (DDR) via modulating the homeostasis of a DNA mismatch repair protein, MSH2, through HDAC6’s ubiquitin E3 ligase activity. Here, we have reported HDAC6’s second potential E3 ligase substrate, a critical cell cycle checkpoint...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moses, Niko, Zhang, Mu, Wu, Jheng-Yu, Hu, Chen, Xiang, Shengyan, Geng, Xinran, Chen, Yue, Bai, Wenlong, Zhang, You-Wei, Bepler, Gerold, Zhang, Xiaohong Mary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600810/ https://www.ncbi.nlm.nih.gov/pubmed/33020410 http://dx.doi.org/10.3390/cells9102237

Ejemplares similares

Implications of the HDAC6-ERK1 feed-forward loop in immunotherapy
por: Wu, Jheng-Yu, et al.
Publicado: (2018)

Depletion of HDAC6 Enhances Cisplatin-Induced DNA Damage and Apoptosis in Non-Small Cell Lung Cancer Cells
por: Wang, Lei, et al.
Publicado: (2012)

The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53
por: Hu, Chen, et al.
Publicado: (2020)

Implications of the USP10-HDAC6 axis in lung cancer - A path to precision medicine
por: Zhang, Xiaohong Mary, et al.
Publicado: (2016)

A Kinome Screen Identifies Checkpoint Kinase 1 (CHK1) as a Sensitizer for RRM1-Dependent Gemcitabine Efficacy
por: Zhou, Jun, et al.
Publicado: (2013)

MMP14 Contributes to HDAC Inhibition-Induced Radiosensitization of Glioblastoma
por: Zhou, Yuchuan, et al.
Publicado: (2021)

Ubiquitination and Degradation of Ribonucleotide Reductase M1 by the Polycomb Group Proteins RNF2 and Bmi1 and Cellular Response to Gemcitabine
por: Zhang, Yingtao, et al.
Publicado: (2014)

CHK2 is involved in the p53-independent radiosensitizing effects of valproic acid
por: Choo, Dong Wan, et al.
Publicado: (2017)

The Chk1 inhibitor MK-8776 increases the radiosensitivity of human triple-negative breast cancer by inhibiting autophagy
por: Zhou, Zhi-rui, et al.
Publicado: (2017)

A Method for Biomarker Directed Survival Prediction in Advanced Non-Small-Cell Lung Cancer Patients Treated with Carboplatin-Based Therapy
por: Chen, Wei, et al.
Publicado: (2013)

HDAC inhibitor confers radiosensitivity to prostate stem-like cells
por: Frame, F M, et al.
Publicado: (2013)

MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells
por: Bridges, Kathleen A., et al.
Publicado: (2016)

Chk1, Chk2, is the amplifier on?
por: Dove, Alan W.
Publicado: (2001)

Impact of CHK2-small interfering RNA on CpG ODN7909-enhanced radiosensitivity in lung cancer A549 cells
por: Chen, Wei, et al.
Publicado: (2012)

Downregulation of CDC20 Increases Radiosensitivity through Mcl-1/p-Chk1-Mediated DNA Damage and Apoptosis in Tumor Cells
por: Gao, Yang, et al.
Publicado: (2020)

Dominant mutations in CHK1 cause pronuclear fusion failure and zygote arrest that can be rescued by CHK1 inhibitor
por: Zhang, Honghui, et al.
Publicado: (2021)

Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells
por: Moertl, Simone, et al.
Publicado: (2019)

Time dependent modulation of tumor radiosensitivity by a pan HDAC inhibitor: abexinostat
por: Rivera, Sofia, et al.
Publicado: (2017)

Regulation, targets and functions of CHK
por: Zhu, Shudong, et al.
Publicado: (2022)

HDAC6 and Ovarian Cancer
por: Haakenson, Joshua, et al.
Publicado: (2013)

A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
por: Gill, Martin R., et al.
Publicado: (2016)

Editorial: Regulation and dysfunction of CSK and CHK
por: Zhu, Shudong, et al.
Publicado: (2023)

Regulated Degradation of Chk1 by chaperone-mediated autophagy in response to DNA damage
por: Park, Caroline, et al.
Publicado: (2015)

Corrigendum: A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
por: Gill, Martin R., et al.
Publicado: (2016)

Icaritin Synergistically Enhances the Radiosensitivity of 4T1 Breast Cancer Cells
por: Hong, Jinsheng, et al.
Publicado: (2013)

Regulation of Chk1
por: Tapia-Alveal, Claudia, et al.
Publicado: (2009)

Modulation of the Ribonucleotide Reductase-Antimetabolite Drug Interaction in Cancer Cell Lines
por: Zhou, Jun, et al.
Publicado: (2010)

Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling
por: Tsai, Yu-Chieh, et al.
Publicado: (2023)

Focused ultrasound radiosensitizes human cancer cells by enhancement of DNA damage
por: Zhang, Xinrui, et al.
Publicado: (2021)

Keeping RelApse in Chk: molecular mechanisms of Chk1 inhibitor resistance in lymphoma
por: Black, Elizabeth M., et al.
Publicado: (2022)

INHIBITION OF ANDROGEN RECEPTOR ACTIVITY BY HISTONE DEACETYLASE 4 THROUGH RECEPTOR SUMOYLATION
por: Yang, Yonghua, et al.
Publicado: (2011)

MK-8776, a novel Chk1 inhibitor, exhibits an improved radiosensitizing effect compared to UCN-01 by exacerbating radiation-induced aberrant mitosis
por: Suzuki, Motofumi, et al.
Publicado: (2017)

RNF157 attenuates CD4(+) T cell-mediated autoimmune response by promoting HDAC1 ubiquitination and degradation
por: Wang, Peng, et al.
Publicado: (2023)

CHK2-FOXK axis promotes transcriptional control of autophagy programs
por: Chen, Yuping, et al.
Publicado: (2020)

Tumour growth environment modulates Chk1 signalling pathways and Chk1 inhibitor sensitivity
por: Massey, Andrew J.
Publicado: (2016)

Trial Watch: Targeting ATM–CHK2 and ATR–CHK1 pathways for anticancer therapy
por: Manic, Gwenola, et al.
Publicado: (2015)

CHK2 Promotes Metabolic Stress-Induced Autophagy through ULK1 Phosphorylation
por: Guo, Ran, et al.
Publicado: (2022)

PIWIL2 suppresses Siah2-mediated degradation of HDAC3 and facilitates CK2α-mediated HDAC3 phosphorylation
por: Zhang, Yingying, et al.
Publicado: (2018)

Radiosensitization effect by HDAC inhibition improves NKG2D-dependent natural killer cytotoxicity in hepatocellular carcinoma
por: Liu, Yu-Fan, et al.
Publicado: (2022)

The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer
por: Xu, Wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q25k40q4vru57fq6mnlrsu9rft